#ACR22 Abstr#0359 Is 2021 DORIS remission attainable in #lupus? Pooled analyses of Anifrolumab RCTs showed this was met in ~10% patients in treatment group vs 3% placebo. Faster and sustained too @Rheumnow https://t.co/5MY2O8i2gA https://t.co/PUeUY25JZl
Links:
Attainment of Remission with Anifrolumab: A Post Hoc Analysis of Pooled TULIP-1…
http://bit.ly/3UMmx3L
12-11-2022
